BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Doxorubicin
,
rs2476601
,
KLK3
,
Coagulation
,
Hepatitis
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Oridonin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
PLAT
HMOX1
SYT1
PLAC1
MYO6
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
ENK_UV_RESPONSE_KERATINOCYTE_UP
OSMAN_BLADDER_CANCER_UP
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast cancer MCF7 cells treated with 102 traditional Chinese medicinal components
Explore Curated Studies Results
Literature
Most Relevant Literature
The bioavailability enhancement and insight into the action mechanism of poorly soluble natural comp…
Preparation, characterization, and pharmacokinetics of oridonin-loaded liposomes.
Single-Cell Transcriptomics Reveals the Ameliorative Effect of Oridonin on Septic Liver Injury.
Oridonin suppresses the growth of glioblastoma cells via inhibiting Hippo/YAP axis.
Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ